Comerica Securities,Inc. Repligen Corp Transaction History

Comerica Securities,Inc.

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 10, 2023	BUY	$162.42 - $220.56 $47,751 - $64,844	294 New	294 $49,000
Q1 2022 Apr 28, 2022	SELL	$161.19 - $257.96 $129,919 - $207,915	-806 Closed	0 $0
Q4 2021 Feb 10, 2022	SELL	$247.59 - $304.47 $2,971 - $3,653	-12 Reduced 1.47%	806 $213,000
Q3 2021 Nov 10, 2021	BUY	$194.77 - $324.21 $159,321 - $265,203	818 New	818 $236,000

488

54.2M

341K

235K

Ticker RGEN
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 55,491,200
Market Cap $8.59B
Description
Repligen Corporation develops and commercializes bioprocessing technologies and systems for use in biological drug manufacturing process in North America, Europe, the Asia Pacific, and internationally. It offers Protein A ligands that are the binding components of Protein A affinity chromatography resins; and cell culture growth factor products....

Get notified when there are updates to the investment portfolio of Comerica Securities,Inc., based on Form 13F filings with the SEC.

Stay updated on Comerica Securities,Inc. with notifications on news.